Hawaii's Flavored Tobacco Ban Fails to Progress in Legislation

Mar.27.2023
Hawaii's Flavored Tobacco Ban Fails to Progress in Legislation
Hawaii flavor ban on tobacco products stalled in state legislature amid concerns over youth vaping crisis.

Recently, according to a report by KITV, a Hawaii media outlet, the state's bill to ban flavored tobacco products (HB511) did not get scheduled for a hearing before March 23rd. This means that the bill will not continue to move forward in the state legislature's agenda.


81% of teenagers use flavored tobacco products.


Advocates of the bill claim that Hawaii is in the midst of a "youth vaping crisis" and argue that it is essential to move the bill forward in order to protect young people. This comes in response to the bill being postponed by the legislature.


According to the legislation, 81% of adolescents who have used tobacco products reported that flavored tobacco was their first choice.


According to the 2019 Hawaii Youth Risk Behavior Survey, 59% of high school students and 38% of middle school students in Hawaii have used mint-flavored tobacco products.


Nikkya Taliaferro, a member of the Campaign for Tobacco-Free Kids, believes that if young people are attracted to these enticing flavors, the tobacco industry will have a new demographic of smokers to continue their harmful business.


Therefore, it is evident that the flavors of tobacco products are appealing to young people.


Previously reported by 2FIRSTS, an electronic cigarette store owner in Hawaii believes that classifying flavored tobacco devices as illegal will only increase black market sales, resulting in children purchasing the electronic cigarette products they need from these sources.


An industry expert added that some adult smokers rely on e-cigarettes to quit traditional cigarettes. However, lawmakers reiterated that the ban will apply to flavored products, while adults will still be able to purchase unflavored e-cigarettes.


The new bill is being regarded with hope.


Currently, the legislation designed to ban flavored tobacco products has not passed through a hearing. Advocates of the bill are hopeful for Senate Bill 1447, which proposes to once again allow each county to enact its own tobacco regulations, overturning the legislation from 2018.


According to Talia Flores, "In the past five years, legislation specifically regarding tobacco has been under the control of the state government, and during these five years, they have not passed any laws that would help protect Hawaii's youth.


Bill Status | Source: Hawaii State Legislature


According to a search by 2FIRSTS on the official website of the Hawaii State Legislature, SB 1447 was reviewed by the Consumer Protection and Commerce (CPC) Committee on March 22 and will now be submitted for consideration by the Hawaii Finance Committee (FIN).


Smoke-free Children's Movement | Source: Smoke-free Children's Movement Official Website


The Campaign for Tobacco-Free Kids is a US-based non-profit membership organization that advocates for reducing tobacco consumption. It has been referred to as a leading anti-tobacco organization by The New York Times. The organization's mission is to change public attitudes towards tobacco and promote effective policies to reduce tobacco use and save lives, as stated in its self-introduction.


Related Reading:


Hawaii to Reinstate Flavored Tobacco Ban; Experts Warn it Could Lead to an Expansion of the E-Cigarette Black Market.


Reference:


A proposed bill in Hawaii that aimed to prohibit the sale and distribution of flavored tobacco products has failed to pass. The bill, which had originally gained support from anti-smoking advocates and health officials, was struck down, much to their disappointment. This decision has been met with criticism from those who believe that flavored tobacco products are targeted towards children and young adults, thereby increasing the likelihood of addiction and tobacco use. The debate surrounding the availability of flavored tobacco products is ongoing, particularly as the use of e-cigarettes has grown in popularity and concerns about youth vaping continue to be raised.


HB 551 Bill Text


The official website of the Smoke-free Children's Movement.


SB 1447 Bill



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
DOJO launched the BLAST10K Fresh in the UK on September 4, 2026, introducing its INSTA-JUICED™ technology and a new 0+10ml structure that keeps e-liquid separated from the coil before activation. The device features a 1000mAh rechargeable battery, COREX BLAST dual-mesh technology and SSS leak-resistant technology, with a manufacturer-rated capacity of up to 10,000 puffs. It also retains compatibility with existing 2+8ml pods across the BLAST ecosystem. The launch introduces eight new flavors, including Matcha Strawberry, which DOJO describes as an industry first.
Market
Sep.04
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei Industrial Co., Ltd. disclosed several oral nicotine-related patent applications in August 2026, including two that approach staged nicotine release from different directions. One uses a high-viscosity membrane that forms inside the pouch after contact with saliva to slow rapid early release, while the other uses gradient particles with a faster-disintegrating outer layer and a slower core to create a fast-to-sustained release profile. Together, the filings explore how nicotine pouches could balance initial delivery with release later in use.
Sep.03
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08